Interferon inhibits transformation by murine sarcoma viruses before integration of provirus

Authors:
  • RAR. J. Avery
    R. J. Avery
  • JNJ. D. Norton
    J. D. Norton
  • JJJ. S. Jones
    J. S. Jones
  • DBD. C. Burke
    D. C. Burke
  • AMA. G. Morris
    A. G. Morris

Abstract
Neoplastic transformation by C-type retroviruses requires synthesis of a DNA copy (the provirus) of the RNA genome and its integration into the host cell DNA. Interferon (IFN) can stably prevent transformation of murine fibroblasts by the Kirsten strain of murine sarcoma virus (KiMSV) and a murine leukemia virus (MLV). Cell clones (IFN clones), isolated in the presence of IFN (104 U ml-1) from cultures of NIH-3T3 [mouse fibroblast] cells which were treated with IFN, and then infected with KiMSV (KiMLV) in conditions where every cell was infected, were phenotypically untransformed. These untransformed cells did not produce virus or contain rescuable KiMSV. Cells isolated using an identical procedure, but in the absence of IFN, were uniformly transformed and all produced KiMSV (KiMLV) or contained rescuable KiMSV. IFN prevents synthesis or integration of the provirus, or else in the presence of IFN the provirus is integrated such that it is not expressed. Five representative clones contain no detectable KiMSV proviral DNA and the initial stages of infection by KiMSV (KiMLV) are inhibited by IFN treatment. IFN seems to act before integration, preventing the synthesis or the integration of proviral DNA.

This publication has 19 references indexed in Scilit: